MM-459 Safety and Clinical Activity of Belantamab Mafodotin With Lenalidomide Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): DREAMM-6 Arm-A Interim Analysis

Authors :: Hang Quach
Mercedes Gironella
Cindy Lee
Rakesh Popat
Paul Cannell
Ravi S. Kasinathan
Bikramjit Chopra
Rachel Rogers
Geraldine Ferron-Brady
Seema Shafi-Harji
Nashita Patel
Joanna Opalinska
Ira Gupta
Bradley Augustson
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S423-S424
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools